Vivos Therapeutics, Inc. Debt Instrument, Convertible, Conversion Price
Vivos Therapeutics, Inc. (VVOS) had Debt Instrument, Convertible, Conversion Price of $1.50 per share as of 2019-04-19, per its 10-K filed 2021-03-25.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2021-03-25
- 2019-04-19: Debt Instrument, Convertible, Conversion Price $1.50.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2019-04-19 | $1.50 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |